Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Sasaki

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1989
Randomized controlled study of mitomycin C/carboquone/5-fluorouracil/OK-432 (MQ-F-OK) therapy and mitomycin C/5-fluorouracil/doxorubicin (FAM) therapy against advanced liver cancerY Sakata, Y Komatsu, S Takagi, et al.
Nihon Seirigaku Zasshi. Journal of the Physiological Society of Japan|January 1, 1982
[Slow component of potential changes in the eyelid elicited by flash stimulation, with special reference to the eye movement]T Ozaki, Y Hoshina, S Teramoto, et al.
Clinical Therapeutics|January 1, 1985
Treatment of irritable bowel syndrome with prifinium bromideD Sasaki, A Suzuki, Y Yoshida, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1986
[Chemoembolization therapy with cisplatin.lipiodol (CDDP.lipiodol) in primary liver cancer--with special reference to hepatocellular carcinoma]H Yodono, K Tarusawa, J Kanehira, et al.
Nihon Seirigaku Zasshi. Journal of the Physiological Society of Japan|May 1, 1983
[Characteristics of eyelid potential changes evoked by phonic stimulation--with special reference to the relation with the eye movement]T Ozaki, Y Hoshina, S Teramoto, et al.
Experimental Parasitology|September 25, 2007
BmSI-7, a novel subtilisin inhibitor from Boophilus microplus, with activity toward Pr1 proteases from the fungus Metarhizium anisopliaeSergio D Sasaki, Cássia A de Lima, Diogo V Lovato, et al.
The Japanese Journal of Antibiotics|December 1, 1989
[Clinical evaluation of imipenem/cilastatin sodium against severe infections complicated with hematological disorders and solid tumors]H Takemori, Y Sakata, H Ogasawara, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|January 1, 1990
[Factors of gastric lesions following after transcatheter arterial embolization for primary hepatoma]H Ishigaki, T Suto, D Sasaki, et al.
Veterinary Parasitology|February 28, 2016
BmTI-A, a Kunitz type inhibitor from Rhipicephalus microplus able to interfere in vessel formationTatiane S Soares, Felipe Oliveira, Ricardo J S Torquato, et al.
Experimental Parasitology|August 2, 2005
The role of HiTI, a serine protease inhibitor from Haematobia irritans irritans (Diptera: Muscidae) in the control of fly and bacterial proteasesSimone S Azzolini, Sergio D Sasaki, Ivan T N Campos, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Cancer Chemotherapy and Pharmacology|January 1, 1989
Randomized controlled study of mitomycin C/carboquone/5-fluorouracil/OK-432 (MQ-F-OK) therapy and mitomycin C/5-fluorouracil/doxorubicin (FAM) therapy against advanced liver cancerY Sakata, Y Komatsu, S Takagi, et al.
Nihon Seirigaku Zasshi. Journal of the Physiological Society of Japan|January 1, 1982
[Slow component of potential changes in the eyelid elicited by flash stimulation, with special reference to the eye movement]T Ozaki, Y Hoshina, S Teramoto, et al.
Clinical Therapeutics|January 1, 1985
Treatment of irritable bowel syndrome with prifinium bromideD Sasaki, A Suzuki, Y Yoshida, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1986
[Chemoembolization therapy with cisplatin.lipiodol (CDDP.lipiodol) in primary liver cancer--with special reference to hepatocellular carcinoma]H Yodono, K Tarusawa, J Kanehira, et al.
Nihon Seirigaku Zasshi. Journal of the Physiological Society of Japan|May 1, 1983
[Characteristics of eyelid potential changes evoked by phonic stimulation--with special reference to the relation with the eye movement]T Ozaki, Y Hoshina, S Teramoto, et al.
Experimental Parasitology|September 25, 2007
BmSI-7, a novel subtilisin inhibitor from Boophilus microplus, with activity toward Pr1 proteases from the fungus Metarhizium anisopliaeSergio D Sasaki, Cássia A de Lima, Diogo V Lovato, et al.
The Japanese Journal of Antibiotics|December 1, 1989
[Clinical evaluation of imipenem/cilastatin sodium against severe infections complicated with hematological disorders and solid tumors]H Takemori, Y Sakata, H Ogasawara, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|January 1, 1990
[Factors of gastric lesions following after transcatheter arterial embolization for primary hepatoma]H Ishigaki, T Suto, D Sasaki, et al.
Veterinary Parasitology|February 28, 2016
BmTI-A, a Kunitz type inhibitor from Rhipicephalus microplus able to interfere in vessel formationTatiane S Soares, Felipe Oliveira, Ricardo J S Torquato, et al.
Experimental Parasitology|August 2, 2005
The role of HiTI, a serine protease inhibitor from Haematobia irritans irritans (Diptera: Muscidae) in the control of fly and bacterial proteasesSimone S Azzolini, Sergio D Sasaki, Ivan T N Campos, et al.
Pageof 8